ALUR
Allurion Technologies, Inc.
NYSE: ALUR · HEALTHCARE · MEDICAL DEVICES
$0.74
-0.03% today
Updated 2026-04-29
Market cap
$8.96M
P/E ratio
—
P/S ratio
0.52x
EPS (TTM)
$-16.20
Dividend yield
—
52W range
$0 – $4
Volume
3.2M
WallStSmart proprietary scores
34
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C5.0
Quality
C+2.5
Profitability
F6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$5.50
+643.24%
12-Month target
—
—
Intrinsic (DCF)
$4.94
Margin of safety
+77.73%
0 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 77.73% below intrinsic value
Risks
- Thin margins at -1.88%
- Negative free cash flow $-6.54M
- Revenue declining -0.51% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $38.24M | $64.21M | $53.47M | $32.11M | $17.21M |
| Net income | $-12.39M | $-37.74M | $-80.61M | $-26.15M | $-11.88M |
| EPS | — | — | — | — | $-16.20 |
| Free cash flow | $-15.24M | $-48.53M | $-65.59M | $-42.91M | $-6.54M |
| Profit margin | -32.39% | -58.78% | -150.76% | -81.43% | -1.88% |
Peer comparison
Smart narrative
Allurion Technologies, Inc. trades at $0.74. Our Smart Value Score of 34/100 indicates the stock is weak. TTM revenue stands at $17.21M. with profit margins at -1.88%. Our DCF model estimates intrinsic value at $4.94.
Frequently asked questions
What is Allurion Technologies, Inc.'s stock price?
Allurion Technologies, Inc. (ALUR) trades at $0.74.
Is Allurion Technologies, Inc. overvalued?
Smart Value Score 34/100 (Grade F, Strong Sell). DCF value $4.94.
What is the price target of Allurion Technologies, Inc. (ALUR)?
The analyst target price is $5.50, representing +643.2% upside from the current price of $0.74.
What is the intrinsic value of Allurion Technologies, Inc. (ALUR)?
Based on our DCF model, intrinsic value is $4.94, a +77.7% margin of safety versus $0.74.
What is Allurion Technologies, Inc.'s revenue?
TTM revenue is $17.21M.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.52x
ROE—
Beta-0.46
50D MA$1.19
200D MA$1.91
Shares out0.01B
Float0.00B
Short ratio—
Avg volume3.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—